Sigma-Aldrich Corporation  

(Public, NASDAQ:SIAL)   Watch this stock  
Find more results for GREEN MILLER, JR
+0.08 (0.06%)
Real-time:   10:46AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 138.52 - 138.70
52 week 93.74 - 139.15
Open 138.52
Vol / Avg. 161,303.00/737,804.00
Mkt cap 16.57B
P/E 33.29
Div/yield 0.23/0.66
EPS 4.17
Shares 119.43M
Beta     -
Inst. own 85%
May 5, 2015
Sigma-Aldrich Corp Annual Shareholders Meeting - 11:00AM EDT - Add to calendar
Apr 22, 2015
Q1 2015 Sigma-Aldrich Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 12, 2015
Q4 2014 Sigma-Aldrich Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 18.87% 17.95%
Operating margin 23.97% 24.45%
EBITD margin - 30.41%
Return on average assets 13.03% 12.50%
Return on average equity 17.12% 16.60%
Employees 9,300 -
CDP Score - 99 A-


3050 Spruce St
ST. LOUIS, MO 63103-2530
United States - Map
+1-314-7715765 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of biochemical and organic chemical products, kits and services which are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company�s business units are research, applied and SAFC commercial. Research includes chemicals, reagents and kits enable scientists to discover and develop new drugs and materials. Applied include high quality components and kits, chemical reagents, critical raw materials and certified reference standards, provide customized solutions to and constitute critical components and among others. SAFC commercial develops and manufactures product and service solutions for the commercial production of pharma, biopharma and electronics products.

Officers and directors

Barrett A. Toan Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Rakesh Sachdev President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Jan A. Bertsch Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Gilles A. Cottier Executive Vice President, President - SAFC Commercial
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eric Mark Green Executive Vice President; President - Research
Age: 45
Bio & Compensation  - Reuters
Franklin D. Wicks Jr. Executive Vice President; President - Applied
Age: 61
Bio & Compensation  - Reuters
George Lloyd Miller J.D. Senior Vice President, General Counsel, Secretary
Age: 60
Bio & Compensation  - Reuters
Karen J. Miller Senior Vice President - Corporate Development and Corporate Communications
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Kanan CPA Vice President, Corporate Controller
Age: 51
Bio & Compensation  - Reuters
Michael Hollenkamp Vice President, Treasurer
Bio & Compensation  - Reuters